Anti-NCF1 / Neutrophil cytosolic factor 1 / p47phox

Adding 0.2 ml of distilled water will yield a concentration of 500 ug/ml. The NCF1 antibody targets Neutrophil cytosolic factor 1, a cytoplasmic component of the NADPH oxidase complex responsible for generating reactive oxygen species (ROS) during immune responses. Encoded by the NCF1 gene, this protein, also known as p47phox, acts as an organizer subunit that bridges cytosolic oxidase components with the membrane-bound catalytic core. The NCF1 antibody is a vital reagent for understanding how oxidative bursts are initiated in phagocytes and how these processes regulate host defense, inflammation, and redox signaling.Neutrophil cytosolic factor 1 becomes phosphorylated upon cellular activation, prompting its translocation to the plasma membrane where it associates with p22phox, gp91phox (CYBB), and other subunits to assemble the active NADPH oxidase complex. This enzymatic system produces superoxide radicals essential for microbial killing. The NCF1 antibody enables detection of this phosphorylation-dependent activation and helps identify conditions that modulate oxidase assembly.Genetic defects in NCF1 lead to chronic granulomatous disease (CGD), a primary immunodeficiency characterized by recurrent infections due to defective superoxide generation. In such patients, mutations often cause reduced or absent p47phox expression. Using the NCF1 antibody, researchers can distinguish functional versus nonfunctional protein forms, aiding in diagnostic and mechanistic studies of CGD. Beyond innate immunity, Neutrophil cytosolic factor 1 also contributes to redox-dependent signaling in endothelial and neuronal cells, highlighting its importance beyond phagocytes.The NCF1 antibody is suitable for western blotting, immunoprecipitation, and flow cytometry, where it detects both total and phosphorylated protein forms. Its applications extend to studies examining oxidative stress, cell signaling cascades, and inflammatory pathway regulation. Because NADPH oxidase activity affects vascular tone, apoptosis, and cytokine production, NCF1 has broad physiological relevance. The antibody provides a reliable means to quantify expression changes under oxidative or inflammatory stress.In oncology and cardiovascular research, aberrant activation of NCF1-containing complexes has been associated with chronic inflammation and tissue damage. Elevated expression may amplify ROS production, promoting DNA damage and tumorigenesis. Conversely, impaired function can weaken immune defense and tissue repair. The NCF1 antibody offered by NSJ Bioreagents supports detailed exploration of these opposing roles, helping define how redox balance influences health and disease.By providing consistent detection across multiple platforms, the NCF1 antibody remains an essential reagent for studying oxidative metabolism and immune cell function. Its use continues to expand from immunology into neurobiology and cancer biology, where understanding reactive oxygen mechanisms is increasingly central to therapeutic innovation.